Company / R&D per Share
AETHLON MEDICAL INC R&D per Share History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.96
FY2024
5-year range
$0.10 / $0.96
FY2020-FY2024
Trend
+488.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +489% YoY in FY2024, a notable deviation from the 9-year average annual change of +625%.
Based on SEC 10-K filings.
0.96 in FY2024 with a 10-year CAGR of +60.9%.
Improved from $0.23 to $0.96 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +113.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- +60.9%
Key checks
Key Insights
- In FY2024, r&d per share increased 488.7% year-over-year.
- Lowest r&d per share in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.96 | +488.7% |
| FY2023 | $0.16 | -27.7% |
| FY2022 | $0.23 | +128.3% |
| FY2021 | $0.10 | -86.0% |
| FY2020 | $0.71 | +1300.1% |
| FY2018 | $0.05 | -50.8% |
| FY2017 | $0.10 | +1.5% |
| FY2016 | $0.10 | -69.9% |
| FY2015 | $0.34 | +3944.8% |
| FY2014 | $0.01 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026